toxoplasmosis: A parasitic disease contracted by the ingestion or fetal transmission of toxoplasma gondii.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpoints |
953 |
6. Filter based on genotype QC (FinnGen only) |
953 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
Protozoal diseases
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 6426 | 2933 | 3386 |
| Only index persons | 5431 | 2564 | 2867 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.09 | 0.08 | 0.09 |
| Only index persons | 0.10 | 0.09 | 0.11 |
| Median age at first event (years) | |||
| Whole population | 46.07 | 44.91 | 47.33 |
| Only index persons | 44.50 | 43.08 | 45.77 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 953 | 479 | 474 |
| Unadjusted period prevalence (%) | 0.19 | 0.16 | 0.21 |
| Median age at first event (years) | 55.17 | 50.84 | 59.55 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 830
- Matched controls
- 8298
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
+∞
323.0
367
*
TGC00
NOMESCO Finland
Bronchial lavation
36.3
165.4
215
79
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
12.3
118.4
231
253
UGC12
NOMESCO Finland
Flexible bronchoscopy
10.2
110.2
239
317
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
13.9
101.4
183
165
B59
ICD-10 Finland
Pneumocystosis
+∞
99.0
93
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
12.2
97.1
187
193
R50.9
ICD-10 Finland
Fever, unspecified
6.3
92.2
291
659
J18.9
ICD-10 Finland
Pneumonia, unspecified
5.0
89.8
375
1171
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.7
68.9
525
2636
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.9
67.8
213
457
XW000
NOMESCO Finland
Bone marrow biopsy
9.8
62.1
132
157
H32.0*B58.0
ICD-10 Finland
Toxoplasma chorioretinitis
+∞
61.2
58
*
ZX108
NOMESCO Finland
Inhalation
39.7
60.3
76
21
B50.9
ICD-10 Finland
Plasmodium falciparum malaria, unspecified
+∞
54.8
52
*
JN4BD
NOMESCO Finland
Extensive body CT
4.8
53.9
203
522
H02AB06
ATC
prednisolone; systemic
3.1
52.5
514
2851
L03AA02
ATC
filgrastim; parenteral
10.7
50.5
101
106
ZX120
NOMESCO Finland
Intravenous
4.8
47.0
173
428
JN4AD
NOMESCO Finland
Body CT examination
5.3
46.0
153
338
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
8.0
46.0
109
153
WW500
NOMESCO Finland
Blood transfusion
8.1
45.9
108
150
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
7.3
45.8
116
180
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
4.6
45.1
174
451
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
9.4
42.9
92
109
B54
ICD-10 Finland
Unspecified malaria
+∞
42.0
40
*
A03FA01
ATC
metoclopramide; systemic, rectal
3.3
41.3
263
1034
A04AA01
ATC
ondansetron; systemic, rectal
5.3
38.2
124
264
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.7
37.3
350
1753
M04AA01
ATC
allopurinol; systemic
3.7
36.3
181
584
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.8
36.2
130
308
L04AA06
ATC
mycophenolic acid; systemic
12.5
36.2
66
57
J01FF01
ATC
clindamycin; systemic
2.7
36.0
321
1552
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
11.7
35.6
67
62
127
Kela drug reimbursment
Transplant complication
14.6
35.3
60
44
L03AA13
ATC
pegfilgrastim; parenteral
7.0
34.1
88
139
D70.82
ICD-10 Finland
Drug-induced neutropenia
14.1
33.7
58
44
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
10.1
33.4
68
73
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.8
32.5
117
277
H02AB02
ATC
dexamethasone; systemic
3.7
31.8
154
480
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
6.3
31.5
87
151
Z51.5
ICD-10 Finland
Palliative care
5.2
31.3
102
216
J01MA12
ATC
levofloxacin; systemic
2.9
31.3
226
942
GD1AD
NOMESCO Finland
Thorax CT examination
6.0
31.3
90
164
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
12.4
31.3
57
49
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
7.0
31.2
80
125
J01MA14
ATC
moxifloxacin; systemic
4.1
31.0
132
368
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.4
30.9
173
604
J05AB11
ATC
valaciclovir; oral
3.4
30.7
169
583
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
13.8
30.0
52
40
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.0
29.4
194
757
B58.9
ICD-10 Finland
Toxoplasmosis, unspecified
+∞
28.3
27
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.6
27.8
103
250
L04AX01
ATC
azathioprine; systemic
5.5
27.2
83
163
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
14.9
26.4
44
31
13000
ICD-8 Finland
Toxoplasmosis, Acquired
+∞
26.2
25
*
A02BC02
ATC
pantoprazole; systemic
2.2
26.0
573
4134
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
7.4
24.7
60
87
WW200
NOMESCO Finland
Immunization
6.6
24.5
64
103
L04AD01
ATC
ciclosporin; systemic
8.8
24.4
53
64
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.0
24.2
61
93
C03CA01
ATC
furosemide; systemic
2.3
24.2
277
1461
A04AA02
ATC
granisetron; systemic, transdermal
4.3
24.1
95
244
D70.89
ICD-10 Finland
Neutropenic splenomegaly
15.7
24.0
39
26
1CX01
NOMESCO Finland
NA
48.2
23.4
28
6
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.6
23.3
112
343
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.2
23.2
92
238
N02AA05
ATC
oxycodone; systemic
2.8
22.6
164
671
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
14.8
22.3
37
26
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
22.1
22.3
32
15
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
13.7
22.1
38
29
L03AA14
ATC
lipegfilgrastim; parenteral
10.0
22.0
44
46
B58.0
ICD-10 Finland
Toxoplasma oculopathy
+∞
22.0
21
*
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
15.0
21.8
36
25
H02AB07
ATC
prednisone; oral
2.6
20.8
169
736
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
20.8
220
1102
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
16.3
20.7
33
21
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
8.3
20.2
45
57
R4110
NOMESCO Finland
Physiotherapy
2.2
20.0
263
1457
TK800
NOMESCO Finland
Hemodialysis
8.0
19.8
45
59
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
13.1
19.5
34
27
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.9
19.4
133
520
Z3231
NOMESCO Finland
Registered nurse
2.1
19.1
267
1515
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
16.3
18.9
30
19
H32.0
ICD-10 Finland
Chorioretinal inflammation in infectious and parasitic diseases classified elsewhere
+∞
18.8
18
*
J05AB01
ATC
aciclovir; systemic
2.3
18.8
204
1029
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.0
18.6
306
1852
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
18.4
333
2089
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.5
18.3
159
714
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
45.1
18.3
22
5
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
9.4
18.0
37
41
1302A
ICD-9 Finland
Toxoplasmosis, Chorioretinitis due to toxoplasmosis
+∞
17.8
17
*
ZX112
NOMESCO Finland
Subcutaneous
6.2
17.3
47
80
WF049
NOMESCO Finland
Radiotherapy of metastasis
5.3
17.3
53
105
H02AB04
ATC
methylprednisolone; systemic
2.5
17.2
152
687
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
17.9
17.0
26
15
A41.9
ICD-10 Finland
Sepsis, unspecified
4.8
16.8
57
126
13099
ICD-8 Finland
Toxoplasmosis, Unspecified
+∞
16.7
16
*
1XC02
NOMESCO Finland
NA
13.8
16.6
28
21
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
6.9
16.5
41
62
Z94.0
ICD-10 Finland
Kidney transplant status
11.5
16.3
30
27
D64.9
ICD-10 Finland
Anaemia, unspecified
2.9
16.3
106
401
WX892
NOMESCO Finland
Monitored bed care
3.1
16.1
92
320
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
9.7
16.0
32
34
B01AB10
ATC
tinzaparin; parenteral
3.3
16.0
83
269
Z2446
NOMESCO Finland
Social worker
3.3
16.0
84
275
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
15.9
267
1608
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
7.4
15.7
37
52
WW300
NOMESCO Finland
Transfer of autologic stem cells
19.7
15.6
23
12
L04AA01
ATC
[U] ciclosporin; systemic
7.6
15.6
36
49
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.3
15.6
167
830
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.9
15.4
101
383
Z2221
NOMESCO Finland
Medical doctor
2.0
15.3
255
1527
ZXE00
NOMESCO Finland
One hour or less
1.8
15.1
347
2325
Z49.1
ICD-10 Finland
Extracorporeal dialysis
9.2
15.1
31
35
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
9.7
15.0
30
32
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.9
15.0
95
353
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
32.4
14.8
19
6
H30.9
ICD-10 Finland
Chorioretinal inflammation, unspecified
+∞
14.6
14
*
0840A
ICD-9 Finland
Malaria, Falciparum malaria [malignant tertian]
+∞
14.6
14
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.5
14.5
69
209
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
6.0
14.5
40
70
A11CC03
ATC
alfacalcidol; systemic
5.8
14.2
40
72
XF400
NOMESCO Finland
ECG with 12 standard connections
2.2
14.2
162
825
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
12.2
14.1
25
21
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
11.7
13.9
25
22
L01AA02
ATC
chlorambucil; oral
54.3
13.8
16
*
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
20.5
13.8
20
10
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.7
13.6
100
406
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
7.6
13.5
31
42
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
34.7
13.5
17
5
WX726
NOMESCO Finland
High-flow oxygen therapy
142.2
13.5
14
*
J17.3
ICD-10 Finland
Pneumonia in parasitic diseases
142.2
13.5
14
*
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.2
13.5
71
233
JN6AD
NOMESCO Finland
CT of torso and neck
7.5
13.1
30
41
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
13.0
349
2426
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.2
13.0
49
122
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
13.3
13.0
22
17
B03XA02
ATC
darbepoetin alfa; parenteral
7.1
13.0
31
45
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.6
12.9
97
399
L01AA01
ATC
cyclophosphamide; systemic
23.0
12.9
18
8
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
8.2
12.9
28
35
Z3226
NOMESCO Finland
Physiotherapist
2.0
12.9
176
964
M05BX04
ATC
denosumab; parenteral
3.7
12.8
56
159
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.6
12.6
95
391
A07EC01
ATC
sulfasalazine; oral, rectal
2.8
12.6
85
329
WF004
NOMESCO Finland
Palliative radiotherapy
5.8
12.5
35
63
6BA02
NOMESCO Finland
NA
24.7
12.5
17
7
J02AC03
ATC
voriconazole; systemic
24.7
12.5
17
7
R06.0
ICD-10 Finland
Dyspnoea
1.9
12.2
219
1329
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
27.1
12.1
16
6
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.6
12.0
91
374
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.4
11.9
102
452
A12AA04
ATC
calcium carbonate; oral
6.8
11.8
29
44
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
9.8
11.8
23
24
B03XA01
ATC
erythropoietin; parenteral
8.8
11.6
24
28
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
4.5
11.5
40
92
WX002
NOMESCO Finland
Sedation and analgesia
1.9
11.5
185
1073
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
3.2
11.5
61
202
C90.0
ICD-10 Finland
Multiple myeloma
7.6
11.5
26
35
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.3
11.3
57
182
ZXD10
NOMESCO Finland
Scheduled procedure
1.7
11.2
325
2284
C83.1
ICD-10 Finland
Mantle cell lymphoma
17.3
11.2
17
10
B23.1
ICD-10 Finland
HIV disease resulting in (persistent) generalized lymphadenopathy
12.9
11.2
19
15
B24
ICD-10 Finland
Unspecified human immunodeficiency virus [HIV] disease
25.4
11.2
15
6
AA1BD
NOMESCO Finland
Extensive CT of head and brain
4.3
11.2
41
100
A05AA02
ATC
ursodeoxycholic acid; oral
6.2
11.1
29
48
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
11.0
150
817
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
5.4
11.0
32
61
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.9
11.0
189
1126
J01MA02
ATC
ciprofloxacin; systemic
1.7
11.0
320
2250
H30.0
ICD-10 Finland
Focal chorioretinal inflammation
43.9
10.9
13
*
L01BB05
ATC
fludarabine; systemic
43.9
10.9
13
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
10.8
415
3140
WW409
NOMESCO Finland
Other aferesis
21.8
10.7
15
7
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
13.1
10.7
18
14
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.7
10.6
45
125
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.2
10.6
54
174
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.7
10.6
71
275
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.3
10.6
104
493
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
10.2
10.5
20
20
1309X
ICD-9 Finland
Toxoplasmosis, unspecified
+∞
10.4
10
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
3.9
10.3
42
113
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.0
10.1
58
203
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
2.8
10.1
63
233
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.9
10.1
157
899
Z3229
NOMESCO Finland
Other healthcare associate professional
2.4
10.1
85
372
P01BA02
ATC
hydroxychloroquine; oral
2.5
10.0
79
333
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.0
10.0
57
198
PJA10
NOMESCO Finland
Exploration of lymph nodes
7.8
9.9
22
29
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
3.0
9.9
57
200
B99
ICD-10 Finland
Other and unspecified infectious diseases
5.8
9.9
27
48
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
26.4
9.8
13
5
390
Kela drug reimbursment
Ibrutinib
26.4
9.8
13
5
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.0
9.8
38
98
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
3.6
9.8
43
124
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.5
9.7
44
130
A07AA02
ATC
nystatin; oral
2.6
9.6
68
271
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
6.5
9.6
24
38
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
2.9
9.6
57
205
XX3DW
NOMESCO Finland
Time consuming IT work
2.3
9.6
93
439
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.8
9.5
60
223
HA1AA
NOMESCO Finland
X-ray mammography
2.6
9.5
68
273
J01DB01
ATC
cefalexin; oral
1.7
9.5
658
5731
M05BA04
ATC
alendronic acid; oral
2.5
9.5
73
303
B01AB05
ATC
enoxaparin; parenteral
1.7
9.5
256
1743
08410
ICD-8 Finland
Vivax malaria (benign tertian)
+∞
9.4
9
*
B23.8
ICD-10 Finland
HIV disease resulting in other specified conditions
22.0
9.4
13
6
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.2
9.3
102
507
S01BA04
ATC
prednisolone; ophthalmic (corticosteroids, plain)
4.9
9.2
29
61
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
13.9
9.2
15
11
WX720
NOMESCO Finland
Own respiration
3.2
9.2
47
153
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
6.0
9.1
24
41
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
9.1
221
1456
L01XE27
ATC
[U] ibrutinib; oral
37.1
9.0
11
*
TAB00
NOMESCO Finland
Lumbar puncture
3.0
9.0
51
176
N18.0
ICD-10 Finland
End-stage renal disease
7.6
9.0
20
27
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.6
8.9
67
276
H02AB09
ATC
hydrocortisone; systemic
4.0
8.9
34
87
ZX090
NOMESCO Finland
Other technic of radiotherapy
3.9
8.9
35
92
JN3AD
NOMESCO Finland
Abdominal CT examination
2.5
8.9
70
297
A07AA09
ATC
vancomycin; oral
6.9
8.9
21
31
ZXD05
NOMESCO Finland
Urgent procedure
1.7
8.9
249
1709
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
7.3
8.8
20
28
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
14.2
8.7
14
10
J96.0
ICD-10 Finland
Acute respiratory failure
7.8
8.7
19
25
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
4.7
8.7
28
61
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
16.5
8.6
13
8
TPH07
NOMESCO Finland
Cathetrisation of artery
2.1
8.6
95
475
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
27.8
8.5
11
*
B20.6
ICD-10 Finland
HIV disease resulting in Pneumocystis jirovecii pneumonia
90.9
8.4
9
*
A04AA55
ATC
palonosetron, combinations; systemic
3.9
8.4
33
87
ZXE20
NOMESCO Finland
More than three and less than five hours
1.9
8.4
121
670
WZC30
NOMESCO Finland
Teaching
2.0
8.4
112
606
B55.1
ICD-10 Finland
Cutaneous leishmaniasis
+∞
8.3
8
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.9
8.3
133
766
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
10.9
8.3
15
14
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.6
8.2
228
1555
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.1
8.1
30
75
RD210
NOMESCO Finland
NA
4.5
8.1
27
61
Z94.2
ICD-10 Finland
Lung transplant status
33.7
8.1
10
*
J12.8
ICD-10 Finland
Other viral pneumonia
9.0
8.1
16
18
1512
Kela drug reimbursment
Ibrutinib
22.3
8.0
11
5
B02.9
ICD-10 Finland
Zoster without complication
2.5
8.0
61
253
C82.1
ICD-10 Finland
Follicular lymphoma grade II
7.3
8.0
18
25
137
Kela drug reimbursment
Uraemia requiring dialysis
7.3
8.0
18
25
N18.8
ICD-10 Finland
Other chronic renal failure
3.8
7.9
32
87
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
6.7
7.9
19
29
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
13.2
7.9
13
10
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
5.8
7.9
21
37
N05CF01
ATC
zopiclone; oral
1.6
7.9
247
1735
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
7.8
321
2407
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.5
7.8
61
259
A04AD12
ATC
aprepitant; systemic
4.5
7.8
26
59
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
5.4
7.7
22
42
ZXA00
NOMESCO Finland
Right side
1.6
7.7
224
1543
XX1XW
NOMESCO Finland
Extensive written report from radiologist
4.3
7.7
27
65
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.3
7.6
67
299
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
18.6
7.6
11
6
YNB10
NOMESCO Finland
Collection of stem cells for transplant
18.6
7.6
11
6
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
12.0
7.6
13
11
A46
ICD-10 Finland
Erysipelas
1.9
7.5
118
675
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.9
7.5
44
158
XCK10
NOMESCO Finland
Photography of fundus of eye
2.1
7.5
87
444
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.3
7.4
69
319
WX110
NOMESCO Finland
Local anesthesy
1.5
7.3
535
4532
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
8.5
7.3
15
18
R4190
NOMESCO Finland
Nutritional therapy
3.2
7.3
37
121
B50.0
ICD-10 Finland
Plasmodium falciparum malaria with cerebral complications
+∞
7.3
7
*
B51.9
ICD-10 Finland
Plasmodium vivax malaria without complication
+∞
7.3
7
*
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
7.4
7.2
16
22
AA1AD
NOMESCO Finland
CT of head and brain
1.6
7.2
188
1256
E0000UV
ATC
NA
1.5
7.2
295
2203
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
30.3
7.2
9
*
N08.5*M31.3
ICD-10 Finland
Glomerular disorders in Wegener's granulomatosis
30.3
7.2
9
*
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
4.6
7.1
23
51
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
6.1
7.1
18
30
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
7.1
171
1118
RS220
NOMESCO Finland
NA
5.2
7.0
20
39
NH3EA
NOMESCO Finland
Feet X-ray examination with load
4.1
6.9
25
62
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.5
6.9
51
208
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.2
6.9
67
315
SPAT1255
SPAT
Intravenous administration of medicine
2.4
6.8
57
251
WX882
NOMESCO Finland
High dependency care
3.4
6.8
31
94
M31.3
ICD-10 Finland
Wegener granulomatosis
11.0
6.8
12
11
S01CA02
ATC
prednisolone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
5.7
6.8
18
32
GDG10
NOMESCO Finland
Bilateral transplantation of lung
40.4
6.8
8
*
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
16.8
6.8
10
6
TQW99
NOMESCO Finland
Other minor procedure on skin
2.6
6.7
47
188
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.1
6.7
34
112
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
5.0
6.7
20
41
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
6.5
6.7
16
25
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.9
6.6
97
542
ZXA05
NOMESCO Finland
Left side
1.6
6.6
197
1360
JN4CD
NOMESCO Finland
Very extensive body CT
2.7
6.6
42
158
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.7
6.6
130
800
L02BG06
ATC
exemestane; oral
5.4
6.5
18
34
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.3
6.5
57
257
XF600
NOMESCO Finland
Bloodpressure measurement
2.3
6.5
58
266
N19
ICD-10 Finland
Unspecified kidney failure
3.2
6.4
32
104
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
70.4
6.4
7
*
399
Kela drug reimbursment
Venetoclax
70.4
6.4
7
*
L01XX52
ATC
venetoclax; oral
70.4
6.4
7
*
1518
Kela drug reimbursment
NA
70.4
6.4
7
*
H30.2
ICD-10 Finland
Posterior cyclitis
70.4
6.4
7
*
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
7.5
6.4
14
19
DHA10
NOMESCO Finland
Biopsy of cavity of nose
6.6
6.4
15
23
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
2.6
6.3
42
164
WX725
NOMESCO Finland
Noninvasive ventilation
2.5
6.3
45
183
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
11.1
6.3
11
10
D69.5
ICD-10 Finland
Secondary thrombocytopenia
11.1
6.3
11
10
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.3
6.3
56
255
0846X
ICD-9 Finland
Malaria, unspecified
+∞
6.3
6
*
08499
ICD-8 Finland
Malaria, Unspecified forms
+∞
6.3
6
*
B53.0
ICD-10 Finland
Plasmodium ovale malaria
+∞
6.3
6
*
08400
ICD-8 Finland
Falicparum malaria (malignant tertian)
+∞
6.3
6
*
B60.8
ICD-10 Finland
Other specified protozoal diseases
+∞
6.3
6
*
N08.5*M32.1
ICD-10 Finland
Glomerular disorders in systemic lupus erythematosus
+∞
6.3
6
*
9680/3-C77.8
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions
26.9
6.2
8
*
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
3.4
6.2
28
85
R2110
NOMESCO Finland
Giving the first information
2.2
6.2
58
270
J70.2
ICD-10 Finland
Acute drug-induced interstitial lung disorders
12.6
6.1
10
8
EBA10
NOMESCO Finland
Surgical removal of tooth
1.9
6.1
87
483
P01AB01
ATC
metronidazole; oral, rectal
1.5
6.1
293
2247
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
6.1
160
1069
R81
ICPC
Pneumonia
3.0
6.1
32
109
H26.3
ICD-10 Finland
Drug-induced cataract
8.7
6.1
12
14
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.6
6.1
41
163
284
Kela drug reimbursment
Nintedanib and pirfenidone
10.1
6.0
11
11
R03AC02
ATC
salbutamol; inhalant
1.4
6.0
404
3304
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
6.1
6.0
15
25
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
257
165
20.96
310.37
7.5
6.2
iu/ml
366.4
394.9
0.06
49
22
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
249
151
21.97
309.00
2.2
1.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
342
81
65.30
307.65
2.0
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
265
200
17.97
293.66
2.9
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
263
198
17.96
291.76
3.0
1.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
221
119
23.88
288.75
2.1
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
223
148
19.36
263.27
2.9
1.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
273
283
13.12
247.47
3.3
2.8
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
194
114
21.11
242.35
2.5
1.7
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
189
116
20.08
230.95
2.3
1.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
191
130
18.12
221.34
2.3
1.5
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
135
38
41.22
219.45
1.3
1.5
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
151
65
27.42
214.29
2.7
2.0
%
28.4
40.3
—
14
7
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
180
133
16.45
198.99
3.9
3.2
u/ml
932.9
2245.6
0.35
15
13
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
202
182
13.82
198.69
1.9
1.5
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
145
72
23.57
194.06
3.0
1.9
e9/l
1.1
1.2
0.48
103
40
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
155
91
20.15
192.54
2.6
1.8
—
—
—
0
0
(44790049)
150
94
18.75
180.27
2.4
1.6
—
—
—
0
0
(44806118)
150
94
18.75
180.27
2.4
1.6
—
—
—
0
0
(44790047)
150
94
18.75
180.27
2.4
1.6
—
—
—
0
0
(44790048)
150
94
18.75
180.27
2.4
1.6
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
127
65
22.39
167.30
3.4
2.1
e6/l
471.3
769.5
1.43
39
23
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
99
24
45.92
166.34
1.4
1.3
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
118
52
25.76
165.14
2.4
1.8
%
12.7
12.2
0.09
44
28
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
119
61
22.15
156.46
3.8
2.8
%
33.8
42.0
1.01
32
18
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
113
52
24.52
155.32
2.6
1.9
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
361
920
5.71
140.67
3.4
1.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
126
91
15.80
139.83
2.9
1.8
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
121
83
16.55
138.04
3.0
1.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
429
1291
5.22
136.83
3.9
1.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
350
914
5.47
131.57
3.2
1.8
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
285
642
5.91
126.14
6.7
2.7
g/l
8.2
10.7
12.83
277
592
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
340
912
5.24
122.86
10.8
4.4
u/l
260.8
258.1
0.09
329
869
(21494814) CD8 cells/100 lymphocytes in Specimen
74
22
36.38
117.35
2.0
1.6
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
89
52
18.78
109.64
2.6
1.7
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
83
44
20.57
106.88
2.7
1.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
534
2204
4.24
106.64
11.3
4.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
333
974
4.72
106.31
2.3
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
82
45
19.84
103.92
2.8
1.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
367
1174
4.46
103.90
2.6
2.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
65
19
36.64
103.39
2.1
1.7
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
87
55
17.31
103.02
3.5
1.9
e6/l
509.9
635.8
0.33
79
45
(3042631) Mycobacterium sp identified in Specimen
110
122
10.06
91.93
3.1
2.5
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
71
37
20.65
91.93
1.9
2.1
u/ml
142629.3
88880.8
—
16
5
(3003458) Phosphate [Moles/volume] in Serum or Plasma
332
1080
4.18
90.14
13.8
5.9
mmol/l
1.1
1.0
0.79
323
998
(3028433) Virus identified in Specimen by Culture
69
36
20.58
89.26
1.3
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
84
66
13.86
88.14
2.9
1.7
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
171
330
6.10
87.39
3.1
2.0
ug/l
1.0
2.3
0.74
157
295
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
88
77
12.49
86.44
1.5
1.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
564
2687
3.69
85.51
17.9
5.9
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
87
78
12.17
84.10
3.1
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
87
78
12.17
84.10
3.1
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
87
78
12.17
84.10
3.1
1.7
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
102
121
9.32
80.81
2.7
2.6
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
665
3608
3.79
80.48
17.8
6.0
%
0.6
0.7
0.65
648
3368
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
225
592
4.67
80.09
2.7
1.6
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
208
516
4.88
79.63
2.9
1.7
g/l
1.0
1.5
2.58
184
480
(3019069) Monocytes/100 leukocytes in Blood
678
3745
3.81
79.32
18.8
6.3
%
8.8
8.7
0.49
660
3510
(3009445) Proteinase 3 Ab [Units/volume] in Serum
169
352
5.62
79.25
2.8
1.6
u/ml
9.7
11.7
0.17
12
12
(3012095) Magnesium [Moles/volume] in Serum or Plasma
360
1337
3.72
79.18
7.6
3.6
mmol/l
0.8
0.8
0.86
346
1248
(3006504) Eosinophils/100 leukocytes in Blood
673
3726
3.74
77.85
18.1
6.0
%
2.3
2.9
12.80
655
3478
(3002030) Lymphocytes/100 leukocytes in Blood
683
3829
3.77
77.19
18.3
6.0
%
26.3
27.7
1.76
666
3571
(3006315) Basophils [#/volume] in Blood
697
3968
3.82
76.68
16.6
5.8
e9/l
0.0
0.0
1.73
643
3438
(3018010) Neutrophils/100 leukocytes in Blood
675
3770
3.71
76.41
16.8
5.8
%
58.9
57.2
2.35
659
3534
(3001604) Monocytes [#/volume] in Blood
694
3953
3.78
75.98
16.6
5.8
e9/l
0.6
0.6
1.26
638
3414
(3019198) Lymphocytes [#/volume] in Blood
702
4053
3.78
74.66
16.7
5.9
e9/l
2.0
1.9
0.21
654
3580
(3013115) Eosinophils [#/volume] in Blood
706
4095
3.79
74.45
18.5
6.1
e9/l
0.2
0.2
11.91
662
3617
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
46
13
37.13
73.51
1.8
2.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
340
1273
3.60
72.97
2.0
1.8
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
233
676
4.24
72.44
8.6
4.1
%
1.1
0.9
0.62
151
204
(3027945) Reticulocytes/100 erythrocytes in Blood
272
907
3.80
69.14
5.5
2.9
%
2.0
1.8
1.52
252
818
(3021879) Hepatitis B virus core Ab [Presence] in Serum
206
563
4.39
69.14
1.8
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
110
175
6.98
67.56
1.5
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
104
157
7.31
67.04
1.5
1.4
u/ml
88.9
103.3
0.56
15
28
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
77
82
10.13
65.93
3.5
3.9
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
86
109
8.57
64.39
1.3
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
99
148
7.35
64.33
2.2
1.7
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
41
13
32.91
63.28
1.1
1.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
478
2363
3.05
62.30
11.9
4.1
ph
7.4
7.4
0.05
115
431
(3013650) Neutrophils [#/volume] in Blood by Automated count
732
4626
3.51
61.24
30.5
9.3
e9/l
4.2
4.1
0.38
685
4055
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
102
166
6.76
61.18
1.3
1.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
153
364
4.82
60.82
2.6
2.1
g/l
1.5
1.5
0.13
129
318
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
122
239
5.71
60.60
1.8
1.7
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
81
103
8.50
60.43
1.6
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
75
87
9.27
60.17
1.2
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
75
92
8.76
57.56
2.5
2.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
249
874
3.50
57.48
2.2
1.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
213
683
3.73
56.37
5.3
2.8
e9/l
73.5
71.3
0.29
153
534
(3026782) Osmolality of Urine
360
1596
3.02
55.81
4.4
2.7
mosm/kgh2o
544.9
563.6
0.97
338
1365
(4035726)
218
715
3.66
55.72
1.7
1.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
42
21
20.88
54.99
2.5
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
55
47
12.36
54.50
1.6
1.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
587
3404
2.89
54.48
11.9
5.1
g/l
33.6
35.5
9.91
559
3179
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
119
253
5.23
53.80
3.8
2.6
u/ml
0.4
0.3
0.35
79
148
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
93
159
6.37
53.03
1.3
1.3
u/ml
268.1
264.2
0.04
64
98
(3001964) Herpes simplex virus Ag [Presence] in Specimen
42
23
19.06
52.81
1.5
1.6
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
42
24
18.26
51.77
3.9
1.9
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
193
613
3.69
51.48
8.7
4.0
%
0.6
0.5
0.52
107
148
(3048929) Epstein Barr virus Ab [Presence] in Serum
114
243
5.19
51.33
1.4
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
197
639
3.63
50.87
9.1
4.2
%
0.2
0.1
0.44
135
185
(3000850) Epithelial cells [#/volume] in Urine
364
1703
2.84
50.09
4.3
2.5
e6/l
4.7
5.5
0.51
344
1504
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
660
4197
2.86
49.16
17.7
6.6
umol/l
10.4
11.4
1.48
643
3995
(3020779) Urea [Moles/volume] in Serum or Plasma
211
733
3.41
48.82
17.5
7.6
mmol/l
11.1
9.6
2.15
205
698
(3018677) aPTT in Platelet poor plasma by Coagulation assay
297
1262
2.97
48.69
3.7
2.1
s
29.1
29.7
1.11
292
1221
(3024139) IgG subclass 3 [Mass/volume] in Serum
62
74
8.89
48.53
1.5
1.4
g/l
0.4
0.4
0.06
38
53
(3028192) IgG subclass 2 [Mass/volume] in Serum
62
74
8.89
48.53
1.5
1.4
g/l
2.1
2.8
1.58
42
53
(3027135) IgG subclass 1 [Mass/volume] in Serum
62
74
8.89
48.53
1.5
1.4
g/l
6.6
7.6
0.41
39
54
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
514
2910
2.66
47.87
5.8
3.2
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
242
933
3.14
46.94
11.3
8.7
kpa
11.0
12.1
3.20
230
899
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
242
933
3.14
46.94
11.3
8.7
kpa
4.8
5.1
6.26
231
895
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
596
3650
2.69
46.91
16.7
6.4
mmol/l
1.2
1.2
1.85
568
3295
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
630
3967
2.74
46.84
19.6
7.1
mmol/l
1.2
1.2
1.24
525
3352
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
100
206
5.31
46.71
2.6
1.7
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
454
2442
2.64
46.62
5.7
3.2
e6/l
25.5
91.5
1.66
395
1895
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
88
163
5.85
46.13
1.8
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
88
163
5.85
46.13
1.8
1.3
—
—
—
0
0
(4062490)
61
76
8.51
46.12
1.5
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
420
2184
2.65
46.10
5.6
3.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
261
1064
3.00
45.78
1.9
1.6
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
238
928
3.09
45.10
11.3
8.8
mmol/l
0.9
1.2
0.59
188
731
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
261
1081
2.95
44.32
4.2
2.5
%
21.7
23.5
1.24
232
923
(3010375) cycloSPORINE [Mass/volume] in Blood
42
33
13.27
43.69
33.9
34.3
ug/l
108.0
126.6
0.64
35
28
(3018095) Leukocytes [#/volume] in Urine
495
2845
2.54
43.30
6.6
3.7
e6/l
30.4
98.3
3.35
403
2036
(3030467) Casts [#/volume] in Urine by Automated count
422
2252
2.57
43.23
5.7
3.1
e6/l
0.3
0.5
2.78
363
1712
(3004809) Band form neutrophils/100 leukocytes in Blood
74
124
6.39
42.90
8.4
3.6
%
1.5
1.2
0.31
65
108
(3022948) Iron [Moles/volume] in Serum or Plasma
284
1254
2.80
42.57
3.9
2.5
umol/l
11.7
13.3
3.77
268
1159
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
58
75
8.17
42.50
1.9
1.1
u/ml
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
268
1150
2.85
42.40
4.0
2.4
g/l
2.2
2.3
3.70
252
1066
(1616796) Gas panel - Central venous blood
84
162
5.59
42.12
6.2
4.0
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
112
277
4.45
41.90
2.1
1.6
titre
600.0
182.0
—
5
10
(3024980) IgG subclass 4 [Mass/volume] in Serum
74
127
6.23
41.89
1.5
1.8
g/l
0.4
0.8
1.96
50
99
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
141
414
3.82
41.77
10.8
11.2
mmol/l
24.2
24.5
0.50
132
387
(40758558) Short blood count panel - Blood
387
2014
2.55
41.40
22.6
7.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
47
48
10.25
41.25
6.3
3.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
189
676
3.24
41.19
5.6
2.8
g/l
63.2
66.6
5.52
181
618
(3025159) Blasts/100 leukocytes in Blood
175
600
3.35
40.86
8.9
4.2
%
0.1
0.1
0.50
110
160
(3002032) Base excess in Venous blood by calculation
204
768
3.11
40.73
9.4
3.5
mmol/l
1.9
2.0
0.03
167
606
(40757373) Influenza virus identified in Isolate
30
14
22.09
40.22
1.2
2.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
163
544
3.41
39.68
7.2
5.9
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
33
21
16.24
38.45
3.2
1.8
e6/l
152.3
304.4
—
22
9
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
43
43
10.43
38.27
4.1
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
43
43
10.43
38.27
4.1
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
43
43
10.43
38.27
4.1
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
43
43
10.43
38.27
4.0
1.9
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
557
3541
2.38
36.83
27.7
9.6
e9/l
0.0
0.0
0.54
478
2895
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
77
155
5.32
36.77
6.9
3.8
%
58.8
58.4
0.07
77
155
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
74
145
5.45
36.40
2.2
1.4
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
377
2033
2.41
36.28
8.6
3.9
%
89.8
90.1
0.09
365
1992
(3037522) Nuclear Ab [Titer] in Serum
241
1052
2.73
36.25
1.6
1.3
titre
319.3
468.6
1.51
55
228
(3026493) Urate [Moles/volume] in Serum or Plasma
385
2112
2.38
35.46
7.2
2.7
umol/l
3353.8
7083.8
1.09
356
1837
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
129
397
3.60
35.43
9.3
3.7
mmol/l
24.0
24.2
0.24
116
363
(3004588) Protein electrophoresis panel - Serum or Plasma
160
564
3.21
35.41
5.4
2.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
180
690
2.98
34.40
13.5
8.9
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
37
35
10.96
34.16
4.5
2.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
37
35
10.96
34.16
4.5
2.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
37
36
10.65
33.51
4.5
2.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
46
60
8.00
33.39
1.8
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
93
240
4.19
32.74
1.5
1.6
iu/ml
0.5
0.0
0.61
24
46
(3016502) Oxygen saturation in Arterial blood
200
838
2.75
32.23
12.6
9.2
%
94.4
95.7
1.45
194
812
(3036481) Cortisol [Moles/volume] in Serum or Plasma
186
761
2.79
31.31
3.2
2.1
nmol/l
353.3
374.5
0.45
177
709
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
25
14
18.31
30.86
1.4
1.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
48
72
6.97
30.82
1.1
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
42
55
7.94
30.37
1.4
1.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
72
161
4.76
30.37
2.4
2.7
%
15.1
15.9
0.69
35
87
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
91
245
4.00
30.20
1.9
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
508
3277
2.18
30.18
12.6
9.4
inr
1.2
1.2
1.42
156
941
(40768795) Lymph node Pathology biopsy report
49
77
6.65
30.13
1.5
1.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
29
23
12.97
29.86
1.1
1.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
294
1531
2.33
29.54
2.7
1.4
g/l
2.3
2.5
0.70
212
941
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
787
6141
2.62
28.61
23.3
7.8
u/l
82.1
78.8
1.07
770
5775
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
131
467
3.09
28.16
1.7
1.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
317
1737
2.24
27.94
2.4
1.7
mg/l
1.9
1.2
1.01
268
1344
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
37
46
8.33
27.90
12.8
7.3
u/ml
51.6
74.1
0.29
15
15
(3012501) Base excess in Blood by calculation
71
169
4.46
27.70
8.9
4.5
mmol/l
2.5
2.7
0.26
61
115
(3007853) Bacteria identified in Skin by Aerobe culture
204
930
2.52
27.34
2.2
1.7
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
650
4719
2.19
27.28
11.5
5.0
mmol/l
6.7
6.7
0.04
632
4418
(40760892) CBC W Ordered Manual Differential panel - Blood
316
1752
2.20
26.87
13.5
4.6
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
56
112
5.25
26.86
5.8
6.2
mg/l
11.8
10.9
0.58
51
102
(3015377) Calcium [Moles/volume] in Serum or Plasma
430
2687
2.09
26.76
8.9
3.6
mmol/l
2.3
2.4
2.09
405
2353
(3014111) Lactate [Moles/volume] in Serum or Plasma
172
735
2.64
26.28
12.0
7.5
mmol/l
1.4
1.4
0.07
166
706
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
200
923
2.48
26.00
5.9
2.8
umol/l
7.2
8.7
0.56
179
814
(3031040) Bacteria [#/volume] in Urine by Automated count
687
5191
2.16
24.67
6.8
4.4
e6/l
63.0
2721.2
—
7
77
(3052851) Hemolysis interference index of Serum or Plasma
83
242
3.66
24.51
5.0
3.3
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
83
244
3.63
24.21
2.0
1.4
g/l
0.2
0.2
0.07
77
232
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
85
256
3.55
23.91
2.0
1.4
g/l
1.1
1.2
0.24
80
243
(3037467) Urinalysis macro (dipstick) panel - Urine
710
5466
2.17
23.81
7.5
4.2
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
85
257
3.53
23.77
8.2
3.8
mg/l
52.8
76.2
0.43
66
207
(3037756) Immunofixation for Serum or Plasma
70
186
3.98
23.59
2.6
1.7
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
408
2589
2.01
23.50
6.7
3.4
u/l
34.2
33.3
0.12
392
2475
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
84
254
3.53
23.48
8.1
3.8
ratio
1.3
1.8
—
5
24
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
38
60
6.55
23.23
1.1
1.2
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
84
257
3.49
23.06
8.3
3.8
mg/l
56.0
44.1
0.37
66
209
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
99
336
3.17
23.01
2.3
2.2
u/l
42.4
39.8
0.45
88
300
(40765096) Chromosome analysis panel by Banding
27
29
9.55
22.72
1.2
1.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
166
748
2.48
22.49
3.5
2.4
u/l
36.5
33.4
0.40
145
644
(21494434) Karyotype in Bone marrow
44
84
5.44
22.19
1.5
1.3
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
21
16
13.40
22.02
2.1
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
399
2558
1.96
21.91
4.9
2.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
29
36
8.28
21.85
4.5
4.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
269
1504
2.10
21.63
5.0
3.9
ng/l
256.8
329.3
0.31
229
1187
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
148
645
2.53
21.47
3.7
3.0
ng/l
202.5
199.9
0.03
135
582
(3026008) Bacteria identified in Urine by Culture
368
2310
1.97
21.36
3.7
3.0
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
87
286
3.25
21.29
6.1
2.6
g/l
9.5
10.6
0.74
73
248
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
145
633
2.52
20.94
10.6
3.7
mmol/l
1.2
1.2
2.09
136
542
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
328
1991
1.99
20.89
2.8
2.2
mg/l
3.2
3.1
0.37
296
1686
(3024891) Influenza virus A+B Ag [Presence] in Specimen
74
224
3.50
20.63
1.4
1.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
90
308
3.12
20.59
6.0
2.6
g/l
3.7
3.7
0.16
67
229
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
90
308
3.12
20.59
6.0
2.6
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
90
308
3.12
20.59
6.0
2.6
g/l
7.7
7.3
1.07
69
238
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
249
1381
2.09
20.29
4.4
2.7
e6/l
0.9
1.1
0.24
158
789
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
110
429
2.77
19.88
18.0
12.5
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
163
773
2.34
19.54
2.5
2.4
g/l
0.2
0.2
0.68
146
728
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
42
87
5.00
19.35
3.9
2.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
234
1290
2.08
19.25
4.8
2.9
e6/l
1.6
2.0
0.59
146
700
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
30
45
6.85
19.22
3.4
1.8
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
30
45
6.85
19.22
3.4
1.8
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
21
20
10.71
19.16
1.0
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
23
25
9.40
19.15
4.3
4.8
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
84
290
3.08
18.91
6.4
2.6
g/l
3.4
3.1
1.38
67
232
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
69
212
3.43
18.79
2.2
2.3
mg/l
12.7
11.7
0.38
63
195
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
16
10
16.26
18.54
1.9
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
16
10
16.26
18.54
1.9
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
16
10
16.26
18.54
1.9
1.0
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
37
72
5.31
18.28
10.5
3.5
%
60.0
55.6
0.47
26
55
(40760888) Immunoglobulin light chains.free panel - Serum
65
196
3.49
18.22
8.1
4.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
723
5845
1.98
17.90
8.7
4.1
mm/h
18.8
12.1
15.93
699
5394
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
25
33
7.75
17.89
2.0
2.4
ug/l
55.1
67.2
0.30
25
33
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
16
11
14.78
17.65
4.8
7.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
527
3869
1.81
17.61
7.2
4.9
estimate
0.0
0.0
0.00
135
735
(3035350) Ketones [Presence] in Urine by Test strip
527
3870
1.81
17.59
5.4
3.6
estimate
0.0
0.0
0.00
133
732
(3009261) Glucose [Presence] in Urine by Test strip
531
3912
1.81
17.49
5.4
3.6
estimate
0.0
0.0
0.50
129
701
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
24
31
7.92
17.48
1.2
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
42
95
4.58
17.44
13.8
3.9
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
253
1480
1.97
17.42
5.1
3.2
mmol/l
2.5
2.4
0.39
231
1303
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
165
827
2.20
17.20
6.0
3.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
63
194
3.41
17.09
1.2
1.3
—
—
—
0
0
(3024471) HLA-A [Type]
23
29
8.10
17.08
1.0
1.0
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
134
618
2.36
17.01
6.3
3.9
ng/l
111.9
84.1
2.33
124
549
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
121
536
2.44
16.79
5.4
3.6
kpa
4.9
5.1
2.52
112
501
(3015235) Bicarbonate [Moles/volume] in Capillary blood
65
207
3.30
16.72
4.3
2.9
mmol/l
24.5
25.0
0.45
55
184
(3009343) pH of Capillary blood
119
529
2.43
16.38
5.4
3.7
ph
7.4
7.4
2.48
22
68
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
111
479
2.49
16.29
2.3
1.7
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
17
15
11.52
16.24
1.8
2.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
103
430
2.56
16.20
1.6
1.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
76
271
2.96
16.16
5.6
2.8
g/l
0.9
1.4
0.57
68
240
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
56
166
3.52
16.11
1.8
1.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
114
506
2.42
15.72
5.5
3.7
mmol/l
1.4
1.8
0.64
87
383
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
371
2520
1.77
15.57
3.4
2.6
u/l
59.4
56.8
0.38
348
2338
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
61
196
3.26
15.47
1.1
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
348
2324
1.78
15.45
4.5
3.1
ng/l
2040.7
1305.0
1.65
319
1970
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
16
14
11.61
15.34
1.9
1.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
305
1964
1.81
15.27
4.3
2.3
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
71
252
2.96
15.22
5.4
2.6
g/l
35.3
37.6
1.96
65
219
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
67
232
3.03
14.99
1.6
1.3
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
17
17
10.16
14.95
1.9
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
441
3172
1.73
14.94
3.1
2.3
nmol/l
77.5
77.2
0.07
416
2827
(3024932) HLA-DR beta [Type]
21
28
7.65
14.88
1.2
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
127
606
2.26
14.82
1.6
1.7
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
35
78
4.62
14.80
1.4
1.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
504
3767
1.72
14.79
8.0
4.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
18
20
9.15
14.69
1.7
1.6
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
14
11
12.90
14.28
1.5
1.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
454
3330
1.69
14.02
4.6
2.8
ug/l
290.8
140.9
2.38
428
3053
(40768804) Tissue Pathology biopsy report
434
3147
1.70
13.98
2.6
2.1
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
105
477
2.35
13.71
2.0
1.2
u/ml
183.3
255.4
0.48
91
433
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
21
31
6.90
13.62
3.3
2.7
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
770
6565
1.90
13.56
51.7
17.7
%
14.6
13.7
26.06
764
6433
(3021960) Folate [Moles/volume] in Serum or Plasma
291
1908
1.76
13.39
1.8
1.5
nmol/l
19.3
20.5
0.75
261
1604
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
54
176
3.19
13.39
1.7
1.3
e6/l
4.6
43.3
0.73
46
140
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
54
176
3.19
13.39
1.7
1.3
e6/l
187.4
782.3
0.47
49
144
(3044290) Cell count panel - Cerebral spinal fluid
50
157
3.31
13.17
1.7
1.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
53
173
3.19
13.11
2.1
2.3
g/l
119.9
128.6
1.57
39
130
(3011397) Hemoglobin [Presence] in Urine by Test strip
279
1820
1.75
13.01
4.8
3.6
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
19
27
7.16
12.73
2.0
1.8
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
45
136
3.42
12.59
1.1
1.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
130
669
2.09
12.48
6.5
3.7
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
89
394
2.39
12.30
7.2
2.5
%
0.6
0.6
0.17
84
380
(3008152) Bicarbonate [Moles/volume] in Arterial blood
108
524
2.20
12.04
14.0
8.2
mmol/l
24.7
24.5
0.20
102
494
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
37
101
3.77
12.03
1.2
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
150
829
1.96
11.79
5.0
4.6
ug/l
16.9
31.0
0.42
122
696
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
44
138
3.29
11.63
1.3
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
64
251
2.66
11.40
2.2
1.9
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
32
82
4.00
11.36
4.2
2.2
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
28
65
4.41
11.29
1.6
1.2
titre
104.0
95.0
—
5
12
(3021901) Oxygen saturation in Capillary blood
44
141
3.22
11.24
4.0
2.8
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
12
11
11.04
11.08
1.3
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
39
117
3.43
11.05
1.4
1.2
u/ml
1.5
4.4
0.72
12
34
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
341
2431
1.63
11.03
3.1
2.1
u/l
112.6
259.2
3.07
324
2290
(3016018) Differential panel - Cerebral spinal fluid
30
75
4.10
11.00
1.4
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
37
108
3.52
10.93
1.1
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
592
4822
1.60
10.84
3.6
2.9
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
13
14
9.40
10.78
1.2
1.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
33
90
3.76
10.76
1.2
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
34
97
3.60
10.40
1.4
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
61
245
2.59
10.37
1.4
1.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
36
107
3.46
10.36
3.2
2.2
pg
32.0
33.1
0.68
36
107
(3047007) Chlamydophila sp Ab [Presence] in Serum
36
107
3.46
10.36
1.2
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
72
314
2.40
10.29
5.4
3.7
g/l
0.3
0.3
0.00
59
138
(3016650) Hepatitis A virus Ab [Presence] in Serum
43
144
3.08
10.23
1.1
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
32
89
3.69
10.15
1.1
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
61
249
2.55
10.04
1.4
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
41
135
3.13
10.03
1.3
1.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
867
7886
2.10
10.03
48.0
14.4
mg/l
25.5
24.2
0.66
780
6240
(3020891) Body temperature
76
344
2.31
9.99
6.2
4.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
222
1460
1.68
9.66
1.8
1.7
nmol/l
1175.8
1183.2
0.04
181
1097
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
59
244
2.51
9.46
1.4
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
46
172
2.76
9.01
9.8
2.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
401
3074
1.53
8.99
5.0
3.6
ng/l
31.3
50.7
0.90
321
2187
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
14
21
6.75
8.91
1.6
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
21
47
4.55
8.86
3.8
1.8
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
39
135
2.97
8.79
5.9
3.0
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
30
89
3.45
8.68
1.7
1.3
e6/l
2369.1
1655.6
0.36
24
57
(3048879) Bone marrow aspiration report
15
25
6.08
8.67
2.5
1.9
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
19
40
4.83
8.61
2.2
1.7
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
13
8
16.46
8.56
3.9
3.0
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
13
8
16.46
8.56
2.5
4.0
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
36
121
3.05
8.54
1.4
1.2
u/ml
5.4
7.9
0.37
13
55
(3009214) Lutropin [Units/volume] in Serum or Plasma
51
207
2.55
8.52
1.7
1.4
u/l
13.2
9.5
0.78
40
160
(3003327) Ova and parasites identified in Stool by Light microscopy
57
247
2.39
8.29
2.2
1.7
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
16
30
5.41
8.22
2.2
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
114
649
1.86
8.11
3.1
2.7
ml/min/173m2
60.7
65.8
0.57
37
267
(3017817) Protein [Mass] in Urine collected for unspecified duration
27
80
3.44
7.84
6.1
2.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
36
128
2.88
7.76
1.2
1.3
—
—
—
0
0
(4268621)
27
81
3.40
7.70
2.5
2.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
70
342
2.13
7.68
1.4
1.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
25
72
3.54
7.58
1.7
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
652
5635
1.50
7.53
5.7
3.8
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
56
252
2.30
7.50
13.2
8.8
mmol/l
1.4
1.3
0.48
48
223
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
35
125
2.87
7.49
1.1
1.1
—
13.9
—
0
7
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
12
19
6.38
7.25
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
12
19
6.38
7.25
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
12
19
6.38
7.25
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
12
19
6.38
7.25
1.0
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
11
16
6.94
7.16
5.5
1.3
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
26
80
3.31
7.14
1.1
1.2
u/l
57.1
59.0
0.05
20
55
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
115
683
1.78
7.12
2.2
2.4
ug/l
8.4
7.1
0.29
105
609
(3035880) pH of Pleural fluid
19
47
4.10
7.10
1.3
1.2
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
74
382
2.02
7.03
7.8
3.7
%
53.7
48.9
0.83
74
376
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
19
48
4.02
6.91
1.8
1.6
u/l
8.6
4.0
0.33
14
25
(3009542) Hematocrit [Volume Fraction] of Blood
791
7178
1.60
6.83
43.2
15.5
%
38.2
40.0
7.02
554
5113
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
405
3235
1.44
6.82
2.3
2.0
pmol/l
93.9
94.6
0.12
245
1677
(3003694) ABO and Rh group [Type] in Blood
291
2183
1.48
6.81
1.7
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
76
402
1.97
6.74
1.5
1.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
24
73
3.35
6.72
1.1
1.0
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
25
79
3.22
6.60
1.8
1.3
e6/l
12090.2
130844.6
0.73
16
40
(4015189)
12
21
5.77
6.60
3.8
2.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
280
2096
1.48
6.59
6.1
4.0
estimate
0.0
0.0
0.69
117
713
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
62
308
2.08
6.54
5.6
2.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
21
60
3.56
6.46
7.1
4.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
18
46
3.97
6.46
2.4
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
73
390
1.94
6.31
2.3
2.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
22
66
3.39
6.30
1.3
1.5
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
9
5
18.15
6.27
1.2
1.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
28
98
2.91
6.25
1.7
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
57
280
2.10
6.20
3.1
1.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
42
182
2.37
6.16
2.0
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
45
202
2.29
6.10
1.4
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
34
134
2.59
6.09
1.5
1.1
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
10
8
12.62
6.09
1.0
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
20
58
3.50
6.03
2.8
1.7
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
34
135
2.57
6.00
1.5
1.1
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
23
74
3.16
5.92
4.3
2.2
—
1.7
—
0
8
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
38
161
2.42
5.87
1.1
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
49
234
2.15
5.74
1.5
1.4
ug/g
243.0
291.0
0.85
26
135
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
17
46
3.74
5.66
2.5
1.2
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
43
196
2.25
5.64
3.0
3.3
umol/l
33.7
34.7
0.12
38
164
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
18
51
3.58
5.62
1.3
1.4
u/l
5.5
6.4
0.36
12
43
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
9
7
12.96
5.59
1.3
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
72
400
1.87
5.55
6.1
3.7
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
34
141
2.46
5.51
1.3
1.5
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
11
22
5.05
5.27
1.4
1.1
mmol/l
2.2
3.9
1.48
11
17
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
19
59
3.27
5.19
1.7
1.1
u/ml
6.2
0.4
—
9
29
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
17
49
3.51
5.19
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
17
49
3.51
5.19
1.0
1.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
271
2099
1.41
5.11
5.3
3.2
—
—
—
0
0
(3000492) Spirometry study
118
774
1.60
5.03
2.2
1.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
23
82
2.85
5.01
7.2
3.8
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
30
123
2.49
5.00
1.3
1.4
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
15
41
3.70
4.94
3.7
2.4
%
93.1
105.0
0.50
15
41
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
13
32
4.10
4.91
7.0
3.2
u/l
240.1
202.2
0.51
13
32
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
179
1293
1.47
4.90
1.5
1.5
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
23
83
2.81
4.90
1.1
1.1
%
101.9
96.0
0.54
23
77
(3023410) Appearance of Cerebral spinal fluid
23
83
2.81
4.90
1.4
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
187
1363
1.46
4.89
1.3
1.3
iu/ml
53.4
33.0
0.86
62
431
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
22
78
2.86
4.84
1.1
1.1
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
15
42
3.61
4.78
1.2
1.1
ratio
1.1
1.0
—
7
13
(4306422)
28
114
2.50
4.74
1.2
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
14
38
3.72
4.66
1.4
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
44
220
2.05
4.63
1.6
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
28
116
2.46
4.58
1.1
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
363
2991
1.35
4.56
5.8
3.8
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
20
71
2.86
4.41
1.7
1.3
%
32.0
32.1
0.01
14
51
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
590
5238
1.33
4.35
4.6
3.2
u/l
72.1
52.3
3.11
555
4875
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
73
440
1.71
4.33
2.7
3.2
pmol/l
4.1
4.6
3.14
62
378
(3023103) Potassium [Moles/volume] in Serum or Plasma
865
8193
1.60
4.33
47.3
16.9
mmol/l
4.0
4.0
3.43
857
7971
(3048689) Calprotectin [Mass/mass] in Stool
133
928
1.50
4.31
3.2
2.5
ug/g
163.5
130.2
0.56
103
738
(3032057) Clostridioides difficile [Presence] in Stool
10
22
4.58
4.31
2.6
2.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
16
51
3.17
4.22
1.0
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
21
79
2.70
4.18
1.0
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
26
109
2.42
4.17
2.3
1.4
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
9
13
6.98
4.17
2.1
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
143
1023
1.47
4.10
1.4
1.3
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
10
23
4.38
4.09
1.1
1.0
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
12
32
3.79
4.09
1.3
1.4
%
52.7
55.4
0.09
12
23
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
18
63
2.89
4.08
1.3
1.1
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
23
92
2.54
4.07
1.3
1.3
—
62.8
—
0
6
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
884
8436
1.66
4.05
28.2
10.7
u/l
26.4
27.0
0.63
870
8134
(3045462) Protein/Creatinine [Ratio] in Urine
7
7
10.06
4.01
6.4
3.4
g/mol
10.7
37.1
—
7
7
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
17
59
2.92
3.91
1.3
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
17
59
2.92
3.91
1.3
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
17
59
2.92
3.91
1.3
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
16
54
3.00
3.86
1.2
1.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
860
8168
1.54
3.86
46.6
16.8
mmol/l
139.0
139.6
10.26
854
7962
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
56
324
1.77
3.86
4.4
3.6
u/ml
573.2
4388.8
0.66
46
279
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
25
107
2.37
3.85
2.4
1.4
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
17
60
2.87
3.80
1.3
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
17
60
2.87
3.80
1.3
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
17
60
2.87
3.80
1.3
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
12
34
3.56
3.77
1.1
1.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
21
84
2.53
3.73
1.0
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
25
109
2.33
3.71
2.4
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
10
25
4.03
3.70
1.0
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
15
50
3.03
3.70
1.0
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
9
16
5.67
3.66
1.3
1.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
38
198
1.96
3.62
1.2
1.4
miu/ml
217.3
233.3
—
9
92
(3027456) Digoxin [Moles/volume] in Serum or Plasma
31
150
2.10
3.60
3.0
2.9
nmol/l
0.9
0.9
0.17
26
115
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
7
9
7.82
3.56
2.4
2.7
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
46
3.07
3.54
1.2
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
13
41
3.20
3.50
1.5
2.0
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
6
6
10.05
3.50
1.0
1.2
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
6
6
10.05
3.50
1.3
1.2
—
—
—
0
0
(4027681)
14
47
3.01
3.42
1.1
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
38
203
1.91
3.39
1.4
1.2
u/ml
5.7
6.1
—
6
29
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
170
1298
1.38
3.38
1.2
1.3
u/ml
27.7
12.2
0.81
43
495
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
7
10
7.04
3.36
1.1
1.3
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
6
7
8.62
3.26
1.2
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
18
72
2.53
3.22
1.0
1.0
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
7
11
6.40
3.19
1.4
1.0
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
7
11
6.40
3.19
9.0
9.4
mmol/l
5.0
6.5
—
7
11
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
7
11
6.40
3.19
1.0
1.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
19
79
2.43
3.15
1.8
1.4
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
48
284
1.73
3.11
1.6
1.4
iu/l
38.8
28.0
0.91
38
238
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
12
39
3.10
3.09
2.7
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
12
39
3.10
3.09
2.7
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
17
68
2.53
3.05
19.6
1.6
%
9.1
11.0
0.98
17
68
(3001893) Eosinophils/100 leukocytes in Pleural fluid
10
29
3.47
3.05
1.3
1.3
%
5.5
3.9
—
10
22
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
7
12
5.87
3.02
1.0
1.0
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
34
183
1.89
2.99
3.8
2.2
u/l
5680.2
3017.6
0.21
12
73
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
23
107
2.18
2.98
2.4
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
23
107
2.18
2.98
2.4
1.4
—
—
—
0
0
(3025315) Body weight
5
5
10.04
2.98
4.4
1.6
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
5
5
10.04
2.98
5.6
3.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
5
5
10.04
2.98
1.0
1.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
23
108
2.16
2.92
2.4
1.4
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
9
22
4.12
2.88
1.4
1.2
—
—
—
0
0
(4010399)
83
578
1.48
2.76
1.7
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
22
104
2.14
2.76
4.0
2.6
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
12
42
2.88
2.75
1.2
1.2
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
5
6
8.37
2.75
1.0
1.0
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
30
160
1.90
2.73
1.4
1.2
u/ml
40.3
30.4
—
7
12
(3036048) Francisella tularensis Ab [Titer] in Serum
7
14
5.03
2.73
1.1
1.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
132
1002
1.37
2.72
30.6
23.1
inr
1.6
1.3
0.68
13
135
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
20
92
2.20
2.68
1.9
1.5
%
59.8
58.4
0.05
12
63
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
9
24
3.78
2.67
1.0
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
16
67
2.41
2.64
1.6
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
14
55
2.57
2.62
1.1
1.6
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
34
192
1.80
2.61
1.9
1.6
e6/l
6723.8
13434.2
1.03
26
146
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
7
15
4.69
2.60
1.0
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
7
15
4.69
2.60
1.0
1.1
%
105.3
94.4
—
7
15
(40768806) Pleura Pathology biopsy report
19
87
2.21
2.58
2.1
1.6
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
8
20
4.02
2.57
1.0
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
143
1110
1.34
2.56
1.3
1.2
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
6
11
5.48
2.54
2.7
2.6
—
—
—
0
0
(3004451) EKG impression Narrative
13
50
2.62
2.54
1.5
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
857
8238
1.40
2.53
33.5
13.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
93
674
1.42
2.53
5.8
3.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
71
1007
0.68
2.52
3.7
4.6
%
29.1
31.9
1.75
54
670
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
786
7465
1.30
2.48
37.3
13.4
ml/min/173m2
77.6
81.0
3.41
713
6162
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
7
16
4.40
2.47
2.4
1.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
7
16
4.40
2.47
1.3
1.3
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
40
242
1.68
2.44
1.4
1.2
titre
88.6
78.6
—
7
21
(3000919) Neutrophils/100 leukocytes in Pleural fluid
9
27
3.35
2.39
1.2
1.1
%
19.1
33.3
—
9
22
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
12
46
2.63
2.36
1.1
1.3
—
53.3
—
0
6
(3038071) Oxygen [Partial pressure] in Mixed venous blood
7
17
4.14
2.36
6.0
8.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
18
355
0.50
2.33
1.6
1.7
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
9
28
3.23
2.31
1.0
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
11
41
2.70
2.28
4.5
6.4
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
12
47
2.57
2.27
4.3
3.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
20
99
2.04
2.27
1.1
1.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
7
18
3.91
2.25
6.0
8.4
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
5
9
5.58
2.21
1.0
1.0
g/l
18.7
17.4
—
5
9
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
204
1697
1.26
2.17
1.2
1.2
u/ml
0.9
1.5
1.08
36
465
(3021387) Prolactin [Units/volume] in Serum or Plasma
38
236
1.64
2.13
1.4
1.4
mu/l
241.3
289.7
0.74
33
218
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
49
2.47
2.11
1.2
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
87
646
1.38
2.09
2.4
2.2
nmol/l
11.1
13.1
1.29
75
574
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
9
31
2.92
2.07
1.0
1.2
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
10
5.02
2.07
2.8
1.7
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
5
10
5.02
2.07
1.4
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
5
10
5.02
2.07
1.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
5
10
5.02
2.07
1.4
1.0
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
12
50
2.42
2.03
1.1
1.4
—
275.0
—
0
6
(40768793) Breast Pathology biopsy report
29
170
1.73
2.02
1.4
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
116
907
1.32
2.00
1.4
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
635
5945
1.20
1.97
4.3
3.8
pmol/l
14.8
14.8
0.16
580
5370
(3013293) Extractable nuclear Ab [Presence] in Serum
5
11
4.56
1.94
1.8
2.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
78
580
1.38
1.88
1.2
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
34
2.66
1.87
1.3
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
8
28
2.87
1.86
1.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
8
28
2.87
1.86
1.0
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
8
28
2.87
1.86
1.0
1.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
6
17
3.54
1.84
1.0
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
15
73
2.07
1.81
2.4
1.7
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
7
169
0.41
1.79
1.3
1.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
28
447
0.62
1.78
1.1
1.4
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
899
8781
1.42
1.74
60.3
21.3
e12/l
4.2
4.5
33.73
890
8540
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
9
36
2.51
1.74
4.9
2.4
ug/l
25.8
259.7
—
9
29
(3010813) Leukocytes [#/volume] in Blood
899
8782
1.42
1.73
60.4
21.3
e9/l
7.2
6.7
3.63
888
8540
(3007461) Platelets [#/volume] in Blood
898
8776
1.40
1.67
60.5
21.3
e9/l
235.2
247.9
5.61
890
8560
(1761868) Lipid panel - Serum or Plasma
246
2800
0.84
1.64
3.4
2.9
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
12
56
2.16
1.61
2.7
1.6
g/l
1.0
1.0
0.11
12
56
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
16
84
1.92
1.60
1.4
1.2
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
8
32
2.51
1.60
1.1
1.1
—
81.8
—
0
6
(3009508) Creatinine [Moles/volume] in Urine
288
2557
1.18
1.56
4.9
3.2
mmol/l
6.9
7.7
2.16
254
2142
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
15
3.35
1.52
1.6
2.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
53
385
1.40
1.50
5.1
3.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
48
660
0.71
1.50
1.4
1.8
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
70
533
1.34
1.49
3.0
3.1
e9/l
4.3
4.1
0.28
62
422
(3013512) EKG study
264
2335
1.18
1.49
4.5
3.9
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
13
65
2.01
1.49
1.1
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
9
37
2.45
1.48
2.3
1.3
nmol/l
159.6
149.5
—
9
37
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
9
37
2.45
1.48
1.0
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
22
2.74
1.43
1.2
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
9
39
2.32
1.43
1.1
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
10
46
2.19
1.40
1.2
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
10
46
2.19
1.40
1.1
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
17
96
1.78
1.39
1.4
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
269
2399
1.17
1.37
5.2
3.3
mg/l
1438.0
257.0
1.68
193
1538
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
5
17
2.95
1.36
1.8
1.2
ug/l
0.3
0.3
—
5
11
(3033799) Differential panel - Peritoneal fluid
6
24
2.51
1.30
2.5
2.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
115
0.43
1.25
1.6
1.6
—
—
—
0
0
(4198724)
6
25
2.41
1.24
2.0
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
777
8002
0.84
1.24
5.1
5.0
mmol/l
2.7
2.7
1.15
714
7340
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
8
37
2.17
1.21
1.3
1.2
u/ml
—
21.3
—
0
6
(21494755) Public health laboratory ask at order entry panel
55
708
0.76
1.16
1.2
1.4
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
5
20
2.51
1.15
3.4
5.5
—
29.4
—
0
5
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
243
2178
1.16
1.15
1.7
1.7
mmol/l
1.5
1.4
1.34
208
1812
(1761482) Bacteria [#/volume] in Urine by Culture
30
208
1.46
1.14
5.9
4.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
40
293
1.38
1.13
1.8
1.9
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
5
21
2.39
1.09
5.8
6.9
mg/l
8.7
7.3
—
5
21
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
11
59
1.87
1.07
2.0
1.2
ug/l
2.1
3.2
0.60
11
53
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
7
33
2.13
1.05
8.4
1.9
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
48
367
1.32
1.05
1.9
2.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
9
46
1.97
1.03
1.2
1.2
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
9
46
1.97
1.03
1.2
1.3
ug/l
4.9
6.1
—
9
38
(4034850)
17
263
0.64
1.03
17.7
10.4
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
16
99
1.63
1.00
2.3
2.6
mg/l
32.6
22.3
—
5
29
(3034274) Bile acid [Moles/volume] in Serum --fasting
12
69
1.75
0.96
4.3
2.5
umol/l
6.4
5.3
—
7
49
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
740
7173
1.14
0.95
5.3
4.6
mu/l
2.0
2.1
0.22
678
6524
(4281824)
13
77
1.70
0.95
1.2
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
21
141
1.50
0.95
1.6
1.7
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
11
62
1.78
0.94
1.1
1.1
nmol/l
260.5
379.9
—
6
51
(3045414) Leukocytes [Presence] in Urine
44
339
1.31
0.94
2.1
1.7
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
11
63
1.75
0.90
1.0
1.2
—
1.5
—
0
9
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
29
2.08
0.89
1.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
6
29
2.08
0.89
1.0
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
29
2.08
0.89
1.0
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
10
56
1.79
0.88
1.3
2.0
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
11
64
1.73
0.86
1.0
1.2
—
79.0
—
0
6
(3038177) Helicobacter pylori Ab [Presence] in Serum
16
104
1.55
0.85
1.3
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
79
663
1.21
0.84
1.4
1.4
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
6
31
1.94
0.84
3.5
1.3
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
(4146454)
5
100
0.50
0.77
1.4
2.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
79
671
1.19
0.76
1.7
1.9
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
273
2532
1.11
0.75
5.7
4.1
mg/mmol
17.7
9.1
1.72
192
1601
(3028707) Methadone [Presence] in Urine by Screen method
16
108
1.49
0.74
6.4
1.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
63
527
1.21
0.72
1.3
1.2
iu/ml
115.0
150.2
0.34
19
209
(3005082) Progesterone [Moles/volume] in Serum or Plasma
5
26
1.93
0.70
1.2
1.2
nmol/l
40.5
30.3
—
5
21
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
765
7815
0.89
0.70
4.7
4.4
mmol/l
1.4
1.4
1.35
702
7169
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
18
250
0.71
0.68
1.6
1.6
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
10
61
1.65
0.68
1.1
1.0
—
—
—
0
0
(44806420)
5
27
1.86
0.68
2.2
2.9
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
770
7861
0.89
0.68
4.8
4.5
mmol/l
4.6
4.6
0.77
714
7262
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
111
980
1.15
0.68
1.8
1.8
%
1.7
1.5
0.93
90
857
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
7
42
1.67
0.68
1.3
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
7
42
1.67
0.68
1.1
1.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
7
43
1.63
0.67
1.1
1.4
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
28
1.79
0.66
1.6
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
28
1.79
0.66
1.0
1.2
ug/l
10.2
8.8
—
5
28
(1002224) Polysomnography panel
40
323
1.25
0.64
1.0
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
29
1.73
0.64
2.0
3.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
8
49
1.64
0.62
5.9
3.6
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
30
1.67
0.61
1.6
1.1
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
8
51
1.57
0.60
3.0
2.0
—
41.6
—
0
6
(3050129) First trimester maternal screen panel - Serum or Plasma
11
162
0.68
0.59
1.5
1.5
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
8
53
1.51
0.58
1.0
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
182
1676
1.11
0.58
1.7
1.7
pmol/l
463.5
20788175.3
1.20
154
1371
(3013139) Helicobacter pylori Ag [Presence] in Stool
59
504
1.18
0.57
1.3
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
9
62
1.46
0.53
1.9
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
9
62
1.46
0.53
1.9
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
32
259
1.24
0.53
1.8
1.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
219
2340
0.92
0.52
3.6
4.3
%
21.8
21.1
0.22
105
1120
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
46
389
1.19
0.51
1.0
1.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
22
171
1.29
0.50
2.7
2.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
107
0.65
0.49
1.0
1.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
185
1728
1.09
0.45
5.5
4.0
kg/l
1.0
1.0
0.11
29
235
(3020961) Endomysium IgA Ab [Titer] in Serum
42
359
1.18
0.43
1.1
1.1
—
146.8
—
0
9
(4211845)
5
33
1.52
0.41
2.0
3.0
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
0
15
0.00
0.41
0.0
2.1
—
2.9
—
0
6
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
15
0.00
0.41
0.0
1.2
—
1.7
—
0
15
(3000285) Sodium [Moles/volume] in Blood
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
16
205
0.78
0.40
1.5
1.4
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
27
223
1.22
0.40
2.2
2.5
ug/min
175.3
103.8
0.47
20
132
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
5
35
1.43
0.39
1.0
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
33
280
1.18
0.38
1.0
1.1
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
28
235
1.20
0.36
1.6
1.8
nmol/l
45.1
39.7
0.47
28
226
(3011288) Drugs identified in Urine by Screen method
21
171
1.23
0.36
6.0
1.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
82
748
1.11
0.35
2.0
2.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
57
511
1.12
0.33
3.4
2.6
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
6
89
0.67
0.33
1.7
1.6
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
17
138
1.24
0.30
1.5
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
301
2906
1.05
0.29
4.3
5.0
ug/l
2.9
2.5
0.28
267
2586
(3049717) Cytology report of Urine Cyto stain
37
326
1.14
0.29
2.5
2.8
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
10
76
1.32
0.28
1.0
1.1
u/ml
0.6
3.1
—
5
32
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
726
7347
0.95
0.26
6.5
5.9
mmol/mol
39.6
40.0
0.49
683
6784
(40768800) Prostate Pathology biopsy report
16
191
0.83
0.24
1.0
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
38
1.32
0.23
1.2
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
5
41
1.22
0.22
1.0
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
163
1698
0.95
0.21
2.2
3.1
ug/l
0.6
0.8
1.15
116
1118
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
11
0.00
0.21
0.0
1.6
—
0.5
—
0
11
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
11
0.00
0.21
0.0
2.6
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
3.0
—
72.2
—
0
11
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
11
0.00
0.21
0.0
2.6
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
12
98
1.23
0.21
1.1
1.3
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
12
145
0.83
0.21
1.5
1.6
—
—
—
0
0
(44813793)
6
48
1.25
0.20
1.0
1.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
11
131
0.84
0.17
1.5
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
11
131
0.84
0.17
1.5
1.5
—
—
—
0
0
(4024509)
8
69
1.16
0.16
1.0
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
11
130
0.84
0.16
1.5
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
11
130
0.84
0.16
1.5
1.5
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
10
83
1.21
0.15
1.0
1.0
u/ml
1.0
3.1
—
5
34
(3051387) C reactive protein [Mass/volume] in Capillary blood
15
171
0.88
0.14
4.2
3.6
mg/l
30.7
22.0
—
10
107
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
90
0.78
0.14
1.7
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
28
258
1.09
0.12
4.3
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
24
261
0.92
0.11
1.5
1.8
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
757
7526
1.03
0.11
4.4
4.0
mmol/l
1.4
1.3
1.26
691
6875
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
767
7712
0.97
0.11
5.1
4.6
mmol/l
6.0
6.0
0.04
710
6997
(3019225) pH of Specimen
76
789
0.96
0.10
11.8
4.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
89
860
1.04
0.10
1.6
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
28
261
1.08
0.10
4.4
1.4
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
5
62
0.81
0.08
1.2
1.5
promille
1.1
1.2
—
5
51
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
68
1.03
0.08
1.4
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
12
108
1.11
0.07
1.1
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
10
112
0.89
0.07
1.6
1.6
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
84
0.83
0.07
1.3
1.2
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
9
84
1.07
0.07
1.4
1.3
u/l
32.3
29.2
—
9
72
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
92
0.87
0.06
1.1
1.3
nmol/l
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
9
102
0.88
0.06
1.7
1.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
97
989
0.98
0.05
19.1
7.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
17
159
1.07
0.05
1.1
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
10
110
0.91
0.05
1.6
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
10
109
0.92
0.04
1.6
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
27
261
1.04
0.02
4.2
1.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
13
123
1.06
0.01
1.0
1.1
u/ml
0.6
2.9
—
7
53
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
23
223
1.03
0.01
1.3
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
27
263
1.03
0.01
4.5
1.4
—
—
—
0
0
(4094501)
21
214
0.98
0.00
1.0
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
123
0.98
0.00
1.4
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
24
243
0.99
0.00
4.9
1.4
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
11
105
1.05
0.00
1.0
1.1
u/ml
0.3
4.0
—
5
25
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
8
81
0.99
0.00
1.1
1.2
nmol/l
1.3
1.4
—
8
73
(3020491) Glucose [Moles/volume] in Blood
6
65
0.92
0.00
1.2
2.7
mmol/l
7.5
6.5
—
6
41
(3026470) Cobalt [Mass/volume] in Blood
5
57
0.88
0.00
1.8
2.1
ug/l
3.6
3.4
—
5
51
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
190.4
—
0
5
(4212803)
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
106
1060
1.00
0.00
1.5
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
20
200
1.00
0.00
5.6
1.4
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
24.5
—
0
6
(40758358) Immune stain study
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033882) Carnitine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
31.7
—
0
6
(3006442) Creatine [Moles/volume] in Serum or Plasma
5
59
0.85
0.00
1.8
1.4
—
74.8
—
0
6
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
5
57
0.88
0.00
1.8
2.1
ug/l
2.8
2.0
—
5
47
Mortality – FinRegistry
↥Association
Association between endpoint AB1_PROTOZOAL and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_PROTOZOAL | 3.997 [3.21, 4.98] | < 0.001 |
| Birth year | 0.994 [0.99, 1.0] | 0.171 |
During the follow-up period (1.1.1998 — 31.12.2019), 470 out of 1914 females with AB1_PROTOZOAL died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_PROTOZOAL | 3.555 [2.88, 4.38] | < 0.001 |
| Birth year | 0.981 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 575 out of 2159 males with AB1_PROTOZOAL died.
Mortality risk
Mortality risk for people of age
years, who have AB1_PROTOZOAL.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.377% | 0.561% |
| 5 | 2.125% | 3.161% |
| 10 | 5.209% | 8.234% |
| 15 | 9.94% | 14.814% |
| 20 | 17.521% | 24.247% |
Relationships between endpoints
↥Index endpoint: AB1_PROTOZOAL – Protozoal diseases
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data